KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
96,28 $
arrow_upward
+0,54%(+0,52) 1D
95,85 $
arrow_downward
-0,45% (-0,43)bedtimeAfter hours
Closed: 12 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
95,85 $
High
96,67 $
Low
94,32 $
Mkt. cap
7,56 млрд
Avg. vol.
836,14 м.
Volume
368,78 м.
P/E ratio
73,49
52-wk high
99,31 $
52-wk low
37,02 $
EPS
1,31 $
Beta
0,07
Shares outstanding
48,84 млн
No. of employees
366
Open
95,85 $
High
96,67 $
Low
94,32 $
Mkt. cap
7,56 млрд
Avg. vol.
836,14 м.
Volume
368,78 м.
P/E ratio
73,49
52-wk high
99,31 $
52-wk low
37,02 $
EPS
1,31 $
Beta
0,07
Shares outstanding
48,84 млн
No. of employees
366
News stories
From web sources and news partners
Investing.com Canada
·
1 сағат бұрын
RadNet COO Mital Patel sells $3.5M in NASDAQ:RDNT stock
StoneX
·
52 минут бұрын
Nasdaq 100 Forecast: Nvidia CEO Huang is Out – What’s Next for NDX?
CNBC
·
6 сағат бұрын
Watch these levels to know if Nasdaq-100 is set to break out
TradingView
·
5 сағат бұрын
Oragenics gets until February 2028 to regain NYSE listing compliance
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersЛондон, Англия, Ұлыбритания
SectorHealth Care
Industry-
Websitekiniksa.com